Figure 1.
Upregulation of miR-29b in decidua-derived mesenchymal stem cells (dMSCs) from patients with pre-eclampsia. *P < 0.05 when compared to that in normal control subjects.
Upregulation of miR-29b in decidua-derived mesenchymal stem cells (dMSCs) from patients with pre-eclampsia. *P < 0.05 when compared to that in normal control subjects.